Recent Updates
Recently added Catalysts
RDY Positive Sentiment Score: 70/100

Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN : L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.co

Key Takeaway: Dr. Reddy's Laboratories announced the allotment of 1,342 equity shares to employees following the exercise of their stock options under the Dr. Reddy's Employees Stock Option Scheme, 2002. This allotment occurred on February 16, 2023, and is part of the company's commitment to employee benefits. The shares rank equally with existing shares and reflect a total issued share capital increase. This decision aligns with the company’s governance under SEBI regulations, promoting a positive workplace environment.

Market Sentiment Analysis

POSITIVE FACTORS

  • Dr. Reddy's Laboratories is exercising employee stock options, indicating a committed workforce.
  • The allotment of shares reflects positive corporate governance practices.
  • This action may enhance employee satisfaction and retention.
  • Overall, the issuance shows the company's growth and operational stability.

Full Press Release Details

National Stock Exchange of India Ltd. (Stock Code: DRREDDY-EQ)
BSE Ltd. (Stock Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd. (Stock Code: DRREDDY)
Ref: Disclosure under Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015
Sub: Allotment of Equity Shares on exercise of Stock Options under ESOPs
This is to inform you that the Nomination, Governance
and Compensation Committee of the Board of Directors of the Company has approved the allotment of 1,342 equity shares of Rs. 5/- each
of the Company, fully paid up, on February 16, 2023, to employees pursuant to exercise of their Stock Options, as per the following details:
Further, please find enclosed the details as required
under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
This is for your information and records.
For Dr. Reddy's Laboratories Limited
/s/ K. Randhir Singh
K. Randhir Singh
Company Secretary, Compliance Officer & Head-CSR
Details under Regulation 10(c) of the SEBI (Share
Based Employee Benefits and Sweat Equity) Regulations, 2021
1 Company name and address of Registered Office: Dr. Reddy's Laboratories Limited 8-2-337, Road No.3, Banjara Hills, Hyderabad - 500034
2 Name of the Stock Exchanges on which the company's shares are listed: BSE Limited National Stock Exchange of India Limited New York Stock Exchange Inc. (ADRs) NSE IFSC Limited (ADRs)
3 Filing date of the statement referred in Regulation 10(b) of the SEBI (Share Based Employee Benefits) Regulations, 2021 with Stock Exchange: The Schemes were institutionalised under the erstwhile the SEBI (Employee Stock Option Scheme and Employee Stock Purchase Scheme) Guidelines, 1999 and appropriate details under Schedule V were filed. The Schemes comply with provisions of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
4 Filing Number, if any: NA
5 Title of the Scheme pursuant to which shares are issued, if any: Dr. Reddy's Employees Stock Option Scheme, 2002
6 Kind of security to be listed: Equity Shares
7 Par value of the shares: Rs. 5/-
8 Date of issue of shares: February 16, 2023 (Date of allotment on exercise)
9 Number of shares issued: 1,342 equity shares
10 Share Certificate No., if applicable: NA
11 Distinctive number of the share, if applicable: 212926444 to 212927785
12 ISIN Number of the shares if issued in Demat: INE089A01023
13 Exercise price per share: (a) 1,342 equity shares exercised at Rs. 5/- per share
14 Premium per share: Nil
15 Total Issued shares after this issue: 16,65,25,181 (*)
16 Total Issued share capital after this issue: Rs. 83,26,25,905/-
17 Details of any lock-in on the shares: NA
18 Date of expiry of lock-in: NA
19 Whether shares identical in all respects to existing shares if not, when will they become identical? Yes, the shares rank pari passu with the existing shares
20 Details of listing fees, if payable: NA
(*) Total paid up capital after this issue: 166,524,981,
i.e. Rs. 832,624,905 (difference of 200 due to forfeited shares of Rs. 5/- each in September 1988 on account of non-payment of allotment

Frequently Asked Questions

What is the stock code for Dr. Reddy's on NSE?

The stock code for Dr. Reddy's on NSE is DRREDDY-EQ.

How many shares were allotted on February 16, 2023?

A total of 1,342 equity shares were allotted on February 16, 2023.

What is the par value of the shares issued?

The par value of the shares issued is Rs. 5/- each.

What scheme were the shares issued under?

The shares were issued under Dr. Reddy's Employees Stock Option Scheme, 2002.

Do the newly issued shares rank equally with existing shares?

Yes, the newly issued shares rank pari passu with existing shares.

Last updated: Feb 16, 2023